Cargando…
Cutaneous Complications Secondary to Haemostasis Abnormalities in COVID-19 Infection
We describe the case of a patient hospitalized for acute decompensated heart failure in a standard medical ward. During hospitalization, he was diagnosed with COVID-19 and transferred to a special unit. The clinical course was marked by worsening of the respiratory disease, the development of right...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SMC Media Srl
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350970/ https://www.ncbi.nlm.nih.gov/pubmed/32665938 http://dx.doi.org/10.12890/2020_001769 |
_version_ | 1783557372275326976 |
---|---|
author | Lorenzo-Villalba, Noel Maouche, Yasmine Syrovatkova, Aneska Pham, Felix Chahbazian, Jean-Baptiste Pertoldi, Pierre Andrès, Emmanuel Zulfiqar, Abrar-Ahmad |
author_facet | Lorenzo-Villalba, Noel Maouche, Yasmine Syrovatkova, Aneska Pham, Felix Chahbazian, Jean-Baptiste Pertoldi, Pierre Andrès, Emmanuel Zulfiqar, Abrar-Ahmad |
author_sort | Lorenzo-Villalba, Noel |
collection | PubMed |
description | We describe the case of a patient hospitalized for acute decompensated heart failure in a standard medical ward. During hospitalization, he was diagnosed with COVID-19 and transferred to a special unit. The clinical course was marked by worsening of the respiratory disease, the development of right parotiditis and thrombosis of the left internal jugular vein. Therapeutic anticoagulation was initiated and 2 days later, the minimal dermatoporosis lesions previously present in the upper extremities evolved to haemorrhagic bullae with intra-bullae blood clots and dissecting haematomas. Surgical management of the dissecting haematomas was difficult in the context of haemostasis abnormalities. The patient died 29 days after hospital admission. LEARNING POINTS: Single room accommodation should be preferred to double room accommodation in standard wards during the COVID-19 pandemic. Anticoagulation therapy and the presence of lupus anticoagulant may induce cutaneous complications during COVID-19 infection. The discontinuation of anticoagulation therapy did not help improve the management of cutaneous lesions. |
format | Online Article Text |
id | pubmed-7350970 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SMC Media Srl |
record_format | MEDLINE/PubMed |
spelling | pubmed-73509702020-07-13 Cutaneous Complications Secondary to Haemostasis Abnormalities in COVID-19 Infection Lorenzo-Villalba, Noel Maouche, Yasmine Syrovatkova, Aneska Pham, Felix Chahbazian, Jean-Baptiste Pertoldi, Pierre Andrès, Emmanuel Zulfiqar, Abrar-Ahmad Eur J Case Rep Intern Med Articles We describe the case of a patient hospitalized for acute decompensated heart failure in a standard medical ward. During hospitalization, he was diagnosed with COVID-19 and transferred to a special unit. The clinical course was marked by worsening of the respiratory disease, the development of right parotiditis and thrombosis of the left internal jugular vein. Therapeutic anticoagulation was initiated and 2 days later, the minimal dermatoporosis lesions previously present in the upper extremities evolved to haemorrhagic bullae with intra-bullae blood clots and dissecting haematomas. Surgical management of the dissecting haematomas was difficult in the context of haemostasis abnormalities. The patient died 29 days after hospital admission. LEARNING POINTS: Single room accommodation should be preferred to double room accommodation in standard wards during the COVID-19 pandemic. Anticoagulation therapy and the presence of lupus anticoagulant may induce cutaneous complications during COVID-19 infection. The discontinuation of anticoagulation therapy did not help improve the management of cutaneous lesions. SMC Media Srl 2020-06-12 /pmc/articles/PMC7350970/ /pubmed/32665938 http://dx.doi.org/10.12890/2020_001769 Text en © EFIM 2020 This article is licensed under a Commons Attribution Non-Commercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) |
spellingShingle | Articles Lorenzo-Villalba, Noel Maouche, Yasmine Syrovatkova, Aneska Pham, Felix Chahbazian, Jean-Baptiste Pertoldi, Pierre Andrès, Emmanuel Zulfiqar, Abrar-Ahmad Cutaneous Complications Secondary to Haemostasis Abnormalities in COVID-19 Infection |
title | Cutaneous Complications Secondary to Haemostasis Abnormalities in COVID-19 Infection |
title_full | Cutaneous Complications Secondary to Haemostasis Abnormalities in COVID-19 Infection |
title_fullStr | Cutaneous Complications Secondary to Haemostasis Abnormalities in COVID-19 Infection |
title_full_unstemmed | Cutaneous Complications Secondary to Haemostasis Abnormalities in COVID-19 Infection |
title_short | Cutaneous Complications Secondary to Haemostasis Abnormalities in COVID-19 Infection |
title_sort | cutaneous complications secondary to haemostasis abnormalities in covid-19 infection |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350970/ https://www.ncbi.nlm.nih.gov/pubmed/32665938 http://dx.doi.org/10.12890/2020_001769 |
work_keys_str_mv | AT lorenzovillalbanoel cutaneouscomplicationssecondarytohaemostasisabnormalitiesincovid19infection AT maoucheyasmine cutaneouscomplicationssecondarytohaemostasisabnormalitiesincovid19infection AT syrovatkovaaneska cutaneouscomplicationssecondarytohaemostasisabnormalitiesincovid19infection AT phamfelix cutaneouscomplicationssecondarytohaemostasisabnormalitiesincovid19infection AT chahbazianjeanbaptiste cutaneouscomplicationssecondarytohaemostasisabnormalitiesincovid19infection AT pertoldipierre cutaneouscomplicationssecondarytohaemostasisabnormalitiesincovid19infection AT andresemmanuel cutaneouscomplicationssecondarytohaemostasisabnormalitiesincovid19infection AT zulfiqarabrarahmad cutaneouscomplicationssecondarytohaemostasisabnormalitiesincovid19infection |